Oncopharmpod
Duvelisib
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:18:20
- Mas informaciones
Informações:
Sinopsis
The latest #oncopharm approval for duvelisib is discussed as well as the similarities and differences to other PI3K inhibitors previously approved.
